These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Penicillamine hypersensitivity: successful desensitization of a patient with severe hepatic Wilson's disease. Chan CY; Baker AL Am J Gastroenterol; 1994 Mar; 89(3):442-3. PubMed ID: 8122662 [TBL] [Abstract][Full Text] [Related]
24. [Hepatocerebral degeneration (Wilson's disease). 2. Therapy]. Werner T; Weinmann H Med Klin; 1965 Nov; 60(46):1856-9. PubMed ID: 5884683 [No Abstract] [Full Text] [Related]
26. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine]. D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825 [No Abstract] [Full Text] [Related]
27. The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease. Yarze JC Am J Gastroenterol; 1995 Jun; 90(6):1026. PubMed ID: 7771405 [No Abstract] [Full Text] [Related]
28. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet. Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484 [No Abstract] [Full Text] [Related]
29. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease. Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423 [TBL] [Abstract][Full Text] [Related]
30. [The topography of P300 in neuropsychiatric pharmacotherapy. III. Cognitive P300 fields in an organic psychosyndrome (Wilson's disease) before and during treatment with D-penicillamine]. Maurer K; Ihl R; Dierks T EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1988 Jun; 19(2):62-4. PubMed ID: 3135996 [TBL] [Abstract][Full Text] [Related]
31. Wilson's disease in the Commonwealth of Dominica, a case report. Cooles P; Khosla D; Brathwaite A Trop Geogr Med; 1986 Mar; 38(1):84-6. PubMed ID: 3961914 [TBL] [Abstract][Full Text] [Related]
33. [Therapy of neurologic manifestations of Wilson's disease using penicillamine]. Hartl J; Hauftová D Cesk Neurol; 1970 Mar; 33(2):89-93. PubMed ID: 5417217 [No Abstract] [Full Text] [Related]
34. [Early detection and treatment of Wilson's disease]. Sternlieb I Bull Mem Soc Med Hop Paris; 1965 Apr; 116(8):859-62. PubMed ID: 5834270 [No Abstract] [Full Text] [Related]
35. [On the course and therapy of a juvenile Wilson's disease case]. Wallauer P; Harbauer H Dtsch Med Wochenschr; 1967 Jun; 92(26):1187-91. PubMed ID: 6027022 [No Abstract] [Full Text] [Related]
36. [Systemic lupus erythematosus induced by d-penicillamine in Wilson's disease: apropos of a case]. López-Guerra N; Alvarez Lario B; García-Moncó C; Peña Sagredo JL Med Clin (Barc); 1987 Apr; 88(13):552-4. PubMed ID: 3586738 [No Abstract] [Full Text] [Related]
37. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine]. Lange J; Brandt G Med Welt; 1981 Jan; 32(3):109-10. PubMed ID: 7207132 [No Abstract] [Full Text] [Related]
38. [Wilson's disease (experience of long-term treatment with penicillamine---con penicilamina]. Escartín Marín P; García Plaza A; Chantar Barrios C Rev Clin Esp; 1974 Jun; 133(5):451-4. PubMed ID: 4215106 [No Abstract] [Full Text] [Related]
39. [Treatment of Wilson's disease]. Pépin B; Barraine R Cah Coll Med Hop Paris; 1968 Feb; 9(2):184-7. PubMed ID: 5745277 [No Abstract] [Full Text] [Related]
40. Membranoproliferative glomerulonephritis in a patient with Wilson's disease. Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]